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The Ss locus in mice controls the levels of a serum globulin, the Ss protein, which is 
detected with a heterologous antiserum (1, 2). This locus maps in the S region of  H-2, the 
major histocompatibility complex (MHC) 1 of this species (2). Two main alleles have been 
described, Ss-H (high) and Ss-L (low). The amount of Ss protein in serum of Ss-H mice is 
10~20-fold higher than those of Ss-L mice, and all mice which are phenotypically Ss-L 
bear the k allele in the S  region of H-2  (3). 
Injection of serum from Ss-H mice into Ss-L mice yielded antisera which detected a 
variant of Ss whose expression was sex-limited. This variant was named Sip (sex-limited 
prutein) and it was found only in the serum of males carrying the dominant allele (3). 
The mechanism of control of the serum levels of  the Ss and the function of this protein 
is still incompletely understood. The observations of D~mant et al.  (4), confirmed and 
extended by Hansen et al. (5), demonstrated that the Ss protein was part of  the hemolytic 
complement system. Recent evidence showed an immunochemical homology between Ss 
and human C4 (6, 7). However, the functional homology between these two proteins has 
been more difficult to establish since in no instance did the C4 hemolytic activity in sera 
of,Ss-H mice come close to being 20-fold higher than in Ss-L mice (8, 9). Furthermore, 
although in  EDTA-plasma the  Ss  protein  has  an  apparent  mol  wt of about  180,000 
daltons,  which is close to the molecular weight of human C4,  in serum the Ss protein 
appears to be very heterogeneous. For example, upon Sepharose-4B filtration of serum of 
Ss-H mice, the Ss-protein is eluted over a range ofmol wt between 180,000 and 1,000,000 
daltons (3). 
While attempting to resolve these inconsistencies, we found that mouse serum con- 
tains a  relatively large concentration of a  previously undescribed protein with a  high 
affinity for the Ss protein. This Ss-binding protein (Ss-bp) has been purified and charac- 
terized.  Its properties,  which differ from all known complement (C)  components, are 
described in the present paper. 
Materials  and Methods 
Reagents.  The  sources of the reagents  were  as follows: Sephadex  G-200, Pharmacia Fine 
Chemicals, Inc., Piscataway,  N. J.; polyethylene glycol (PEG, mol wt 6,000-7,500), J. T. Baker 
Co., Philipsburg,  N. J.; phenylmethylsulfonyl  fluoride (PMSF), Sigma Chemical Co., St. Louis, 
* Supported by National  Institutes of Health grant no. AI 13224. 
1  Abbreviations used in this paper: BCL, barbital  calcium lactate;  C, complement; CIE, cross 
immunoelectrophoresis; EAC, sheep erythrocytes sensitized with IgG antibody and complement; 
MHC, major histocompatibility  complex; PBS, phosphate-buffered saline;  PEG,  polyethylene 
glycol; PMSF, phenylmethylsulfonyl  fluoride; RIE, rocket immunoelectrophoresis; Slp, sex-lim- 
ited protein; Ss-bp, Ss or C4-binding protein; Ss-H, Ss-high; Ss-L, Ss-low. 
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Mo.;  Pevikon  C-870,  Stockholm  Superfosfat  Fabriks  A.-B.,  Stockholm,  Sweden;  agarose  and 
human transferrin,  Behring Diagnostics,  American Hoechst  Corp.,  Somerville,  N.  J.;  DEAE- 
cellulose (DE-52), Whatman Chemicals, Div. W  & R Balston, Maidstone, Kent, England. 
C4 purified from human serum was a gift from Dr. B. F. Tack. Its sp act was 8.4 ×  10  e CHso U/ 
mg protein and 178 times higher than in the original plasma. In gel electrophoresis a single band 
was obtained with the unreduced material, while reduced C4 gave three bands (10). 
Buffers.  Phosphate-buffered  saline  (PBS)  (Dulbocco's  PBS),  Grand  Island  Biological  Co., 
Grand Island, N. Y. 
PBS-EDTA.  PBS containing 2 mM of Na3H EDTA, pH 7.55. 
Barbital calcium lactate (BCL).  BCL containing 0.023 M sodium barbital, 0.037 M barbituric 
acid, and 0.0009 M calcium lactate. 
Animals.  Mice: 4- to 6-too-old mice, both sexes, from the following strains, were used: DBA/ 
2J, AKR/J, the F2 generation originated from these two strains, A.CA, C3H.OH, C3H.OL, A/Sn, 
A.AL OC3H, B10.D2, and B10.BR. The F2 generations were obtained in our animal facilities from 
AKR/J and DBA/2J parentals purchased from The Jackson Laboratory, Bar Harbor, Maine. The 
congenic and congenic recombinant pairs were donated by Doctors D. C. Shreffler and J. Stimp- 
fling. Mice were bled from the axillary vein and artery into tubes containing NasH EDTA (0.01 M 
final concentration in plasma) or allowed to clot in ice for 1 h. Sera and plasma were used fresh or 
after storage at -70°C. 
C4-deficient and normal guinea pigs were bred in our animal facilities. 
Antisera.  Rabbit anti-mouse C3 and anti-mouse Ig were prepared as described in (11-13). Goat 
anti-human C4 was purchased from Meloy Laboratories, Inc., Springfield, Va. The IgG fraction of 
a  rabbit anti-human transferrin was obtained from Dakopatts A/S, Copenhagen, Denmark. The 
IgG fractions of rabbit and goat antisera to mouse serum were purchased from Cappel Labora- 
tories,  Inc., Downingtown,  Pa.  Rabbit antiserum to Ss and mouse antibodies to Sip were a  gift 
from Dr.  D.  C.  Shreffler. A  rabbit antiserum specific for guinea pig C4 was a  gift from Dr.  M. 
Frank. Antiserum to Ss-bp was obtained as follows: pooled EDTA-plasma from AKR/J male mice 
was passed through a  Sephadex G-200 column. Ss°bp was contained in the first protein peak.  1.5 
mg protein from the pooled fractions of the ascending limb of this peak was emulsified in complete 
Freund's adjuvant and injected in the four footpads of 5- to 6-too-old female rabbits. The animals 
were boosted on day 14 by injecting 0.75 mg of protein intraperitoneally. Bleedings were done on 
days 21 and 24. By cross immunoelectrophoresis of whole mouse plasma, the presence of antibodies 
to Ss-bp and to several contaminants was detected in these antisera.  Because female mice have 
only about 30% of the Ss-bp levels present in males (see text) their sera were used for absorption of 
the contaminant antibodies from the oligo-specific antisera. In addition, antisera were also raised 
against partially purified Ss-bp (see below) by the same method. 
Anti-H-2 antisera, serum designation D1 and D4, directed against private specificities of  K  and 
D  regions, respectively, were obtained from the National Institutes of Health, Bethesda, Md. 
Radiolabeling  of Ss-bp.  This was performed by the method of Hunter and Greenwood (14).  25 
~1 of Tris-HC1,  0.8  M,  pH  7.6,  was  added to  2  mCi of 1~I,  aqueous solution in a  V  vial (New 
England  Nuclear,  Boston,  Mass.)  followed  by  50  ftl  of purifed  Ss-bp  (0.7  mg/ml),  10  ~1  of 
chloramine T (0.5 mg/ml), 10 ~1 of sodium metabisulfite (0.5 mg/ml), and 0.7 ml of PBS. The V vial 
and all reagents were kept in crushed ice. The labeled protein was dialyzed for 48 h against PBS. 
After removal from the dialysis bag, 2 mg of bovine serum albumin in 0.1 ml of PBS was added and 
the mixture stored at 4°C. 
Analytical  Procedures.  Cross  immunoelectrophoresis  (CIE)  and  rocket  immunoelectropho- 
resis (RIE) were done as described (15-17),  by using 5  ×  5-cm glass plates and the BCL buffer 
described above. For CIE, the electrophoresis in the first dimension was performed at 10 V/cm and 
5°C.  Human transferrin was mixed with the antigen in every plate to serve as a  marker.  The 
second dimension took 16 h, at 10°C and 2 V/cm, in agar containing the required antiserum and 
antibodies to human transferrin. The electrophoretic mobility of Ss-bp was compared in each plate 
with the mobility of the transferrin/anti-transferrin peak. The Rf of Ss-bp was defined as the ratio 
between the distances to the origin of the Ss-bp and transferrin peaks. In CIE or RIE, the levels of 
antigen were evaluated by measurement of the peaks after staining. Serial dilutions of standards 
containing each protein were included in each experiment to calculate the relative concentrations 
of the unknowns. RIE was run at 2 V/cm and 10°C for 16 h. A.  FERREIRA,  M.  TAKAHASHI,  AND  V.  NUSSENZWEIG  1003 
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Fro.  1.  Pevikon-block electrophoresis profile of a 0-5% PEG precipitate of mouse (AKR/J, 
male) EDTA-plasma. The precipitate was dissolved in PBS containing 0.002 M EDTA, pH 
7.5, and run at 4°C for 18 h at 5 V/cm. Pevikon fractious were eluted with PBS containing 2 
mM EDTA,  pH 7.5. The presence of Ss-bp (C4-binding protein) was monitored by RIE. 
Linear gradients of 10-40% sucrose in 0.0005  M  phosphate buffer, pH  7.4 containing 0.15 M 
NaCI, 50 mM ~-aminocaproic acid, and 5 mM EDTA were used for sucrose density ultracentrifuga- 
tion. Centrifugation was performed for 18 h  at 36,000 rpm at 4°C by using an SW 50.1 rotor. The 
positions of 19s Ig and albumin were determined by inspection of the optical density pattern of the 
eluted fractions. The positions of Ss-bp and mouse C3 were determined by RIE. The position of IgG 
was monitored by single radial immunodiffusion. The separation of mouse serum into a  lipopro- 
tein-rich and a depleted fraction by ultracentrifugation in KBr (sp gr 1.25) was performed by Dr. 
H.  Kayden.  The  centrifugation was  done  at  40,000  rpm,  4°C,  in  a  Beckman  ultracentrifuge 
(Beckman Instruments, Inc., Cedar Grove, N. J.). 
Pevikon block electrophoresis was carried out as in (18). The separation was carried out for 18 h 
at 4°C, in barbital buffer pH 8.6, F/2 =  0.05, at 6.3 V/cm. 
Statistical Analysis.  The significance between or among means in different experiments was 
assessed by two-tailed t tests or by analysis of variance. The least squares method was used for the 
regression analysis. 
Results 
Purification and Properties of Ss-bp.  The purification  of Ss-bp was moni- 
tored by RIE with  an antiserum monospecific to Ss-bp.  The starting material 
was  EDTA-plasma  of  8-  to  12-wk-old  AKR/J  male  mice.  90  ml  of plasma, 
collected in about 10 ml of 0.1 M Na3H EDTA, pH 7.55, were mixed at 0°C with a 
solution of PMSF. The PMSF was previously dissolved in anhydrous ethanol to a 
concentration of 10-20 mg/ml and added slowly to the plasma to a final concen- 
tration of 0.5 mM. Subsequently, 50 ml of a solution of 15% PEG-6,000 prepared 
in  PBS  containing  15  mM  Na3H  EDTA,  was  added  dropwise,  with  constant 
stirring.  After  20 min  at 0°C,  the precipitate  was collected by centrifugation, 
dissolved in 25 ml of PBS containing 2 mM Na3H EDTA, pH 7.5 and submitted to 
electrophoresis in a Pevikon block. As shown in Fig.  1, Ss-bp moved as a sharp 
band with a fll mobility. The positive fractions, eluted in PBS containing 2 mM 
Na3H  EDTA  pH  7.5,  were  concentrated  to  8  ml  in  an  Amicon  stirring  cell, 
(Amicon Corp., Lexington,  Mass.) by using a PM-30 membrane. The final step 
in  the  purification  consisted  of filtration  through  a  Sephadex  G-200  column 
equilibrated  in the same PBS-EDTA buffer.  Ss-bp was eluted in the exclusion 
volume,  concentrated  to 5  ml,  and frozen  in aliquots  at  -70°C.  Assuming an 1004  04 (Ss)-BINDING  PROTEIN 
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FIG.  2.  Sucrose  gradient  (10-40%) ultracentrifugation of mouse  (AKR/J,  male) EDTA- 
plasma. The positions of the 5s and 19s proteins were determined by the OD profile of the 
fractions. The concentrations of IgG (7s) were determined by single radial immunodiffusion 
and those of Ss-bp and C3 were determined by RIE. 
absorption coefficient value of E 18~mnm =  1 for all serum proteins at a concentra- 
tion of 1 mg/ml, the final recovery of Ss-bp was between 10 and 20%,  and the 
purification factor about  200  times.  After the  first step,  PEG  precipitation, 
recoveries were greater than 95%  and the purification factor close to 30.  The 
final preparation contained at least 35% of Ss-bp as shown by specific precipita- 
tion of the radiolabeled material with a monospecific antiserum. Ss-bp retained 
its antigenicity as well as its affinity for the Ss protein and human C4 after 
heating at 56°C for 30 rain. The sedimentation coefficient of Ss-bp was deter- 
mined  by  subjecting  samples  of plasma  from  AKR/J  male  mice  to  sucrose 
gradient ultracentrifugation (Fig. 2).  A mean value of 10  _+  0.35 was obtained 
from three separate runs. In other determinations with the purified Ss-bp at a 
concentration of 1 mg/ml in PBS, the s values were not significantly  different. 
Effects of  H-2 Type and Sex of Mice on the Levels of Ss-bp.  The H-2 complex 
as well as sex hormones influence the levels of several C components in mice 
(19-23).  Fig. 3 shows the relative levels of Ss-bp in male and female mice of an 
F2 generation of mice derived from crosses between AKR/J and DBA/2J. The 
differences in levels of Ss-bp in serum of mice with different 1-1-2 types are not 
significant. However, the concentration of Ss-bp in serum of males is two and 
one half  times that of  females. This difference is so large and reproducible that it 
permits the determination of the sex of an adult mouse with almost complete 
accuracy by inspection of the CIE pattern of its serum  (Fig.  4).  The absolute 
values for the  serum  levels of Ss-bp  could be  calculated assuming that our 
partially purified preparations contained 35% Ss-bp (see above) and that ~1 cm  J-~280 nm 
=  1 at a concentration of Ss-bp of 1 mg/ml. Based on these assumptions, and on 
results of RIE  with the purified Ss-bp  as  a  standard,  we calculated that the 
levels of Ss-bp in the plasma from 8- to 10-wk-old male and female C3H.OH mice 
were 160 and 60 ftg/ml, respectively. A.  FERREIRA,  M.  TAKAHASHI,  AND  V.  NUSSENZWEIG  1005 
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FIG.  3.  Serum levels of Ss-bp (C4-binding protein) in 8 wk old mice. These animals were 
the F2 generation derived from AKR/J and DBA/2J parentals (AKD2F1 x  AKD2F1). Their 
H-2  type  was  determined  by  hemagglutination  by  using  specific  antisera  against  the 
products of the K and D regions (serum designation D1 and D4, respectively). As estimated 
by analysis of variance, the difference between males and females is highly significant (P < 
0.0005).  However, the differences among males or females bearing different H-2 types are 
not significant. 
Affinity of Ss-bp for Ss.  In plasma collected in EDTA, to prevent C activa- 
tion, Ss and Ss-bp are not associated, and can be almost completely separated by 
filtration  in Sephadex  G-200  (Fig.  5 A).  However, as described below, several 
lines of evidence demonstrate the formation of the Ss/Ss-bp complexes in serum. 
(a) An antiserum to human C4 which cross-reacts with the Ss protein, but not 
with Ss-bp, simultaneously precipitates Ss and Ss-bp from mouse serum.  This 
was demonstrated by a  combination of RIE and CIE of a  B10.A serum (H-2  a, 
Ss-H).  In the first part of the experiment,  the serum was mixed with human 
transferrin  and  subjected to  RIE,  in  the  presence  of various  amounts  of the 
above mentioned  IgG anti-human  C4,  to precipitate the  Ss protein.  Then the 
plates were subjected to  a  second electrophoresis  (CIE),  perpendicular  to the 
first  one,  into  agarose-containing  antibodies  to  Ss-bp  and  transferrin.  The 
presence of antibodies to C4 in the first dimension (RIE) completely abrogated 
the Ss-bp peaks in the second dimension (Fig. 6 A) but did not affect the areas of 
the transferrin-anti-transferrin  peaks. The same result was obtained by incorpo- 
rating an antiserum to Ss (instead of anti-human C4) in the first dimension (not 
shown). 
To rule out the possibility that Ss-bp had bound nonspecifically to the Ss-anti- 
Ss  precipitate  formed in  the  first  dimension,  the  reciprocal  experiment  was 
performed.  An antiserum  to transferrin  rather than to C4 was present in the 
first dimension.  Now (Fig. 6 B) the peak of transferrin  in the second dimension 
was abrogated, but Ss-bp was not affected. 
The same experiments were repeated with an Ss-L serum (C3H.OL) and as 1006  c4  (Ss)-BINDING  PROTEIN 
FIG.  4.  CIE patterns of individual sera from adult male and female mice obtained from a 
cross between AKD2F1  x  AKD2F1.  The 1"t-2 typos were determined as explained in the 
legend of Fig.  3.  Antisera against Ss-bp and human transferrin were used in the second 
dimension. A standard amount of human transferrin was added to each mouse serum as an 
internal marker. The peak of transferrin is easily recognized (stronger line). Comparing the 
positions of the Ss-bp peaks with that of the internal marker, it is clear that Ss-bp moves 
slower towards the anode in H-2 k mice. Also shown is the striking difference in Ss-bp levels 
in sera from males and females irrespective of H-2 type. The anode is on the left. 
predicted, the presence of antiserum to human C4 in the first dimension barely 
affected the Ss-bp peak. On close inspection only a small part of the descending 
limb of the  Ss-bp peak was abrogated  (not shown).  This  represents  the fast 
moving Ss/Ss-bp complexes formed with the small amount of Ss present in this 
serum and which have a  faster electrophoretic mobility (see below). In short, 
these experiments demonstrate that in Ss-H serum all of Ss-bp is bound to Ss, 
while in Ss-L serum most of Ss-bp is not associated with Ss. 
(b) In serum,  part of Ss appears to have higher  molecular weight than  in 
plasma  (Fig.  5B).  As mentioned in  the Introduction  section, the patterns  of 
elution of  the Ss protein, after filtration of EDTA plasma or serum in Sephadex 
G-200 columns, are markedly different. If EDTA plasma is used, Ss appears in 
the ascending limb of the peak which contains 7s Ig (Fig. 5 A). If serum is used, 
most of the Ss is found in the exclusion volume (Fig. 5 B). In the latter case, as 
shown by experiments analogous to those described in Fig. 6, all high molecular 
weight Ss could be precipitated by an antiserum specific for Ss-bp. However, the 
Sip was found only in the second peak. 
Another important point shown in these experiments is that once formed, the 
Ss/Ss-bp complexes cannot be dissociated by chelation of divalent cations. The 
pattern of elution of Ss when serum is passed through Sephadex G-200 columns 
is exactly the same whether the eluting buffer does or does not contain free Ca A.  FERREIRA,  M.  TAKAHASHI,  AND  V.  NUSSENZWEIG  1007 
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FIG.  5.  (A) Sephadex G-200 gel filtration of pooled EDTA plasma from adult B10.D2 (H- 
2% Ss-H, Sip-positive) male mice. Buffer: PBS pH 7.4 EDTA 0.01 M. The relative concentra- 
tions of Ss-bp (C4-binding protein) and Ss were determined by RIE of each fraction by using 
monospecific antisera. The eluting buffer was PBS-EDTA. (B) Sephadex G-200 gel filtration 
pattern of pooled serum from B 10.D2 mice. The eluting buffer was PBS-EDTA. The relative 
concentrations of Ss-bp  and  Ss  (C4) were determined by RIE of each fraction by using 
monospecific  antisera. Sip-positive fractions were found only in the second peak. All Ss in 
the first peak, but not in the second peak, could be specifically  precipitated by anti-Ss-bp. 1008  c4  (Ss)-BINDINO  PROTEIN 
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and Mg ions. Under both conditions, high molecular weight Ss determinants are 
found in the exclusion volume in association with Ss-bp. 
(c) The formation of Ss/Ss-bp complexes in serum could also be detected by 
electrophoresis. The electrophoretic mobility of Ss-bp is not different in EDTA- 
plasma of Ss-H or Ss-L mice. In serum, however, marked differences in mobility 
of Ss-bp have been observed. In Ss-H mice, the Ss-bp moves faster toward the 
anode than  in  Ss-L mice  (Fig.  4).  These differences are  a  consequence of the 
formation of Ss/Ss-bp complexes. When Ss is high, all Ss-bp is bound to Ss and 
the  complexes  are  more  negatively  charged  than  either  protein  in  EDTA- 
plasma. When levels of Ss are low, most of Ss-bp remains free in the serum, and 
its real mobility is apparent.  Indeed, as will be shown in the section below, the 
electrophoretic mobility of Ss-bp in  serum  of Ss-L mice can be shifted by the 
addition to mouse serum of human or guinea pig C4. 
One  interesting  consequence  of the  differences  in  electrophoretic  mobility 
between Ss-bp and the Ss/Ss-bp complexes is that  Ss-bp appears to be a  poly- 
morphic protein in serum. A detailed genetic analysis demonstrating this pseu- 
dopolymorphism in a  series of congenic mice and among the progeny of an F2 
generation obtained by breeding AKR/J (Ss-L) and DBA/2J (Ss-H) is shown in 
Fig.  7.  Without exception,  the sera from mice which were Ss-L had the slow 
variety of Ss-bp. All Ss-H had fast Ss-bp. If the Ss/Ss-bp interactions had been 
unknown, these results would have indicated the presence in the S region of  H-2 
of a  structural  gene controlling the electrophoretic mobility of Ss-bp, with two 
alleles, one of them (slow Ss-bp) linked with the Ss-L gene, and the other (fast 
Ss-bp) linked with the Ss-H gene. 
Interaction of Ss-bp with Human C4 and Guinea Pig C4.  Fig. 8 and Table I 
show that  the  electrophoretic  mobility of Ss-bp changes  when  serum from  a 
C3H.OL mouse (Ss-L) is preincubated at 37°C for 10 min with purified human 
C4. The new position of Ss-bp is similar to that found in serum of Ss-H mice (Fig. 
4). The physical association between activated or native human C4 with Ss-bp in 
Ss-L serum was shown by the  complete abrogation  of the  Ss-bp peak in the 
second dimension of a CIE if anti-human  C4 was present in the agarose during 
the electrophoresis in the first dimension. 
Ss-bp in the serum of Ss-L mice can also bind to guinea pig C4. In Fig. 9 we 
Fro.  6.  Simultaneous precipitation of Ss (C4) and Ss-bp from mouse serum (B10.A, H-2 a, 
Ss-H) by an antiserum specific for human C4. This antiserum cross-reacts with Ss (C4) but 
not with Ss-bp. Mouse serum was mixed with a standard amount of human transferrin and 
many samples were subjected to CIE under different conditions described below. In  all 
cases, the second dimension was developed with  a  mixture of antisera to  Ss-bp and to 
human transferrin. (A) In these plates, increasing amounts of  antibodies to human C4 were 
present in the agarose during electrophoresis  in the first dimension. As seen, the Ss-bp peak 
in the second dimension was eliminated. However, the transferrin peak was not affected. 
(B) In this series of control plates, increasing amounts of antibodies to human transferrin 
were present in the agarose during the electrophoresis in the first dimension. The transfer- 
rin peak, but not the Ss-bp peak, was abrogated. The slope for the regression line for Ss-bp 
levels is not different from zero. The rationale for choosing transferrin-anti-transferrin  as a 
control precipitating system was based on the observation that transferrin moves slightly 
ahead of Ss-bp during the electrophoresis. Therefore, Ss-bp had to migrate through the 
transferrin-anti-trans  ferrin lattice. C4  (Ss)-BINDING  PROTEIN 
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FIG.  7.  Pseudopolymorphism of Ss-bp protein in the serum of congenic mice (top part of 
figure) or in sera from parentals and F2 mice obtained from crosses between AKD2F1  × 
AKD2F1. All mice were adults, between 7 and 8 wk of age. Rfofthe C4-binding protein (Ss- 
bp) were determined by CIE and defined as the ratio of the distances from the origin of the 
Ss-bp peak and transferrin peaks.  The H-2  types of F2  mice were determined either by 
hemagglutination  (see  legend  of Fig.  3)  or  by  measuring the  levels of the  Ss  and  Sip 
proteins. Mice which are Ss-L and Slp° are classified as H-2 k. The others are either H-2 d or 
H-2 dk. As shown, the mobility of Ss-bp was strictly controlled by H-2  and the levels of Ss. 
The slow variety of Ss-bp, without exception, was observed in mice carrying the k allele in 
the H-2 region. The congenic pair C3H.OH and C3H.OL differ only in the S  region of H-2. 
C3H.OH carries the d allele (Ss-H) and C3H.OL carries the k allele (Ss-L). B10.Br, A.AL, 
and AKR/J also  carry the k allele  in the S  region. The A.CA (H-2  I, Ss-H) strain,  as 
expected,  has Ss-bp of  the fast  variety. 
show the progressive change in the Rf of Ss-bp after  the incubation of  serum 
from C3H.OL mice (Ss-L)  with increasing volumes of  normal guinea pig  serum. 
No change was observed in the presence of C4-deficient guinea pig serum. 
Therefore, the change in mobility of Ss-bp was C4-dependent, and, as in the 
experiment above with  human C4, Ss-bp  shifted  from slow  to  fast  electrophoretic 
mobility.  With the highest doses of  guinea pig  serum, the mobility of  Ss-bp was 
similar to  that found in Ss-H serum. That in  these serum mixtures mouse Ss-bp 
was bound to native or activated guinea pig C4, was demonstrated by the 
complete precipitation  of  Ss-bp with antibodies specific  to guinea pig C4 (Table 
II). 
Discussion 
We describe here a protein of mouse serum which specifically binds to C4 of 
man and guinea pig, as well as to the autologous Ss (C4) protein. Its properties 
differ from any other known C components. In view of  its high affinity  for Ss and 
C4, we provisionally named it Ss(C4)-binding protein, or Ss(C4)-bp. 
Ss-bp is a heat stable (56°C, 1 h) B-globulin, with a sedimentation coefficient 
in sucrose density ultracentrifugation of 10s, which is excluded on gel filtration A.  FERREIRA,  M.  TAKAHA8HI,  AND  V.  NUSSENZWEIG  1011 
FIG.  8.  Human C4-mediated shift  of  the electrophoretic  mobility  of  Ss-bp  in serum of 
C3H.OL (Ss-L)  male  mice.  30-~I  Samples  of  mouse  serum  were mixed  with  human transfer- 
rin  and  with  an  equal  volume  either  of  PBS or  of  purified  human C4  (10  ~g).  The  mixtures 
were incubated  at 37°C  for 10 rain  and then subjected  to CIE.  The second dimension 
contained  antisera  to  human transferrin  and  an oligo-specific  antiserum  containing  anti- 
bodies  to  Ss-bp.  The  top  figure  shows  the  pattern  obtained  in  the  absence  of  human C4  in  the 
first  run.  The  Ss-bp  peak  is  the  weak  one  in  the  center  of  the  figure  between  the  transferrin 
peak (left)  and a contaminant (right).  The figure  on the bottom left  shows the pattern 
obtained  in the presence  of  human C4. The Ss-bp  peak is now shiRed and its  position 
coincides  with  the  transferrin  peak.  These patterns  should  be  compared with  those  of  Fig. 
4.  It  is  clear  that  the  new  position  of  Ss-bp  coincides  with  that  of  Ss-bp  in  serum  from  Ss-H 
mice.  The  figure  at  the  bottom  right  should  be  compared with  the  one  at  the  left.  It  shows 
the complete  abrogation  of  the Ss-bp  peak when antibodies  to human C4 (10 /~l)  were 
present during  the electrophoresis  in the first  dimension.  Otherwise,  conditions  were 
identical  in  all  plates. 
in  Sephadex G-200. On the  basis  of  its  ultracentrifugation in  potassium bromide 
it is not a lipoprotein.  Ss-bp is found in relatively  large amounts  in mouse 
plasma, and as  is  the  case for  other  components of  the C system in  mice, such as 
C4 and C5 (3, 19) it  is  found in  higher concentration in  the serum of  males (160 
/~g/ml)  versus females (60 ftg/ml).  No significant differences in  Ss-bp  levels  have 
been found among  mice of  H-2  d (Ss-H) and  1-1-2  k (Ss-L) haplotypes. 
Ss-bp has been  purified about  200 times  from plasma  of Ss-L mice,  by a 
combination of  PEG-precipitation, Pevikon-block electrophoresis, and Sephadex 
G-200  gel filtration,  with yields between  10 and 20%.  The final preparation 
contains at least 35% of  pure Ss-bp as  judged from specific  precipitation  with a 
monospecific antiserum to Ss-bp. Purified Ss-bp does not react with antisera to 
mouse Ig, Ss, or  C3. By using polyvalent antisera  to  mouse serum from different 
sources, only  two unidentified contaminants have beem detected in  this  purified 
Ss-bp preparation. 1012  C4  (8s)-BINDING  PROTEIN 
TABLE  I 
Association between Human C4 and Ss-bp in Serum of Ss-L Mice 
Demonstrated by Cross Immunoelectrophoresis* 
Loaded in anti-  Antibody present during  C4-binding protein peak in the 
gen well  electrophoresis in first di-  second dimension 
mension  Levels~  Rf~ 
Mouse serum plus: 
Human C4  None  130 _+ 3.46  0.98 ± 0.01 
Anti-human C4  Zero  - 
Buffer  None  113 ± 0.00  0.79 -+ 0.00 
Anti-human C4  100 ± 3.76  0.71 _+ 0.01 
* The experimental conditions were described in the legend of Fig. 8. Note that the 
formation of human C4/Ss-bp complexes caused a change in mobility of Ss-bp. The 
formation of the complexes is shown by the complete abrogation of the Ss-bp peak 
by the antibodies to human C4 in the first dimension. The numbers represent the 
means ± SD of triplicate plates. 
* Levels are obtained by measuring the areas under the peaks and comparing them 
to the areas of different dilutions of standards. 
§ Ratio between distances from the origin of the transferrin and Ss-bp peaks. 
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FIG.  9.  Guinea pig C4-mediated  shift of Ss-bp in serum of C3H.OL  (SB-L) mice.  30 ~tl 
samples of mouse serum were mixed with increasing volumes of normal guinea pig serum 
and incubated at 37°C for 10 min. Subsequently, they were mixed with human transferrin 
and subjected to CIE.  Antisera to Ss-bp and human transferrin were used in the second 
dimension. The figure shows a progressive shift of the electrophoretic mobility ofSs-bp (Rf) 
caused by addition of normal guinea pig serum, but not of C4-deficient guinea pig serum. In 
all cases a single symmetrical peak of Ss-bp was observed. 
In mouse EDTA-plasma, Ss and Ss-bp do not seem to be associated since they 
can be almost completely separated by a  single passage through a  Sephadex G- 
200 column. In contrast, in serum of Ss-H mice, most or all of Ss-bp is combined 
to a  portion of the Ss protein. 
Although the formation of the Ss-bp/Ss complexes depends on the presence of 
Ca  ÷÷ and/or Mg  +÷ ions, once formed the bonds between these proteins cannot be A.  FERREIRA,  M.  TAKAHASHI,  AND  V.  NUSSENZWEIG  1013 
TABLE  II 
Association between Guinea Pig C4 and Ss-bp in Serum of Ss-L Mice Demonstrated by 
Cross Immunoelectrophoresis* 
Antibody present during  C4-binding protein peak in the second 
Loaded in antigen well  electrophoresis in first di-  dimension 
mension  Levels$  Rf~ 
Mouse serum plus: 
Normal  guinea  pig  se- 
rum 
None  112  __ 2.89  1.03  -+ 0.01 
Anti-guinea pig C4  Zero  - 
C4-deficient  guinea  pig  None  151  -- 4.90  0.84 +_ 0.00 
serum 
Anti-guinea pig C4  148  _+ 6.03  0.83 +- 0.01 
* The experimental conditions were  described in the legend of Fig.  9.  Note that formation of 
guinea pig C4/Ss-bp complexes caused a  shift in the mobility of Ss-bp.  The formation of the 
complexes is demonstrated by the complete abrogation of the Ss-bp peak when antibodies to 
guinea pig C4 were present during electrophoresis in the first dimension. Numbers are means -+ 
SD of triplicate plates. 
$ Levels are obtained by measuring the areas under the peaks and comparing them to the areas of 
different dilutions of standards. 
§ Ratio between distances from the origin of the transferrin and Ss-bp peaks. 
reversed by chelation of divalent cations. It seems likely that the initial require- 
ment of divalent cations for the formation of the Ss/Ss-bp bonds is related to the 
complement activation which follows clotting of mouse plasma. The C cascade of 
the mouse is known to be particularly  sensitive to activation during clotting. 
Even after the serum is separated from the clot, the  total hemolytic activity 
decays extremely rapidly even if the serum is maintained at low temperatures 
(9). 
Evidence that all Ss-bp in serum of Ss-H mice is associated with Ss derives 
from experiments showing that specific precipitation of Ss leads to coprecipita- 
tion of all of Ss-bp (Fig. 6). A monospecific antiserum to human C4, which cross- 
reacted  with  mouse  Ss,  was  used  to  precipitate  Ss.  Identical  results  were 
obtained by using rabbit antisera to Ss (not shown). Neither antiserum  cross- 
reacted with Ss-bp. Control experiments showed that Ss-bp did not bind nov_spe- 
cifically to unrelated antigen-antibody precipitates. In sera from Ss-L mice most 
of Ss-bp  is  free.  However,  these  sera  do  contain  small  amounts  of Ss/Ss-bp 
complexes, since about 10% of Ss-bp could be precipitated by antibodies to Ss. 
Therefore, the Ss protein from Ss-L serum is not defective in its capacity to bind 
Ss-bp. 
As a  consequence of the formation of the Ss/Ss-bp complexes, the Ss protein 
appears to be heterogeneous in size as determined by passage of mouse serum 
through Sephadex G-200 columns (Fig. 5 B). The molecular weight heterogene- 
ity of Ss in serum had been previously observed by Shreffler and his co-workers 
(3), and attributed to a spontaneous aggregation of Ss. We show here that all Ss 
found  in  the  exclusion  volume  of the  Sephadex  G-200  column  is  in  reality 
associated with Ss-bp. In view of the classical observations of Miiller-Eberhard 
et al.  (24) showing that human C4 and C2 form complexes during C activation, 
the possibility that  Ss-bp is mouse C2 has to be considered.  However, this  is 1014  c4  (Ss)-BINDING  PROTEIN 
unlikely for several reasons. First, C2 is a heat labile trace constituent of serum, 
with a sedimentation rate of approximately 4.5s (25), while Ss-bp is heat stable, 
present  in  large  amounts  in  serum,  and  has  a  sedimentation  rate  of  10s. 
Furthermore,  purified preparations of Ss-bp do not have C2 hemolytic activity.2 
The  association  between  Ss  and  Ss-bp  can  also be  demonstrated  by high 
voltage electrophoresis in agarose at alkaline pH. When Ss binds to Ss-bp, the 
complex becomes more negatively  charged  than  either  protein  alone.  Conse- 
quently, in the serum of Ss-L mice (in which Ss levels are very low and Ss-bp is 
mostly free) Ss-bp appears to have a slower electrophoretic mobility than in the 
serum of Ss-H mice (Fig. 4). The strict dependency of the mobility of Ss-bp on the 
levels of Ss was demonstrated both in congenic mice and in the progeny of a cross 
between Ss-H (DBA/2J) and Ss-L mice (AKR/J). All mice which had the k allele 
in the S  region and therefore low levels of Ss, had the slower variety of Ss-bp 
protein  in  their  serum.  All other  mice had the fast Ss-bp  (Fig.  7).  In  EDTA 
plasma, no differences in mobilities of Ss-bp have been observed among mice of 
different H-2 haplotypes. 
This striking pseudopolymorphism of Ss-bp in serum highlights its specificity 
for an activated form of mouse C4. This specificity is also shown by the observa- 
tion  that  the  slow variety of Ss-bp can  be transformed  in  vitro  into  the fast 
variety  simply  by  the  addition  to  the  Ss-L  serum  of pure  human  C4,  C4- 
sufficient guinea pig serum, but not of C4-deficient guinea pig serum. Although 
many  enzymes  and  complement components  are  activated  during  clotting  of 
mouse blood (9) all Ss-bp becomes associated only with an activated form of C4, 
presumably fluid phase C4b. In a subsequent publication it will be shown that, 
indeed,  Ss-bp  binds  to  sheep  erythrocytes  sensitized  with  IgG  antibody  and 
complement  (EAC1,4b)or  EAC4b,  but  not  to  EACT  or  sheep  erythrocytes 
sensitized with IgG antibody, and that the binding is directly proportional to the 
number of C4b sites on the erythrocyte. 2 
The specific association of C4b and Ss-bp indicates a functional role for Ss-bp 
in  the  classical  C  system.  The  stoichiometry  of the  reaction,  as  well  as  the 
formation of relatively tight bonds between Ss-bp and C4b  2 is reminiscent of the 
interaction  of proteinase  inhibitors  with serum proteinases  (26).  Although  no 
proteinase activity has been associated with C4b, it participates in the assembly 
and  probably modulates  the  activity of the  two key C  enzymes,  C4b,2a  and 
C4b,2a,3b,  whose substrates are,  respectively, C3 and C5. The important  role 
of C4b in these complex enzymes is suggested by the observation that although 
their catalytic site resides in C2a (27),  after dissociation from C4b, C2a retains 
its  capacity  to  hydrolyze  synthetic  esters  but  does  not  have  C3-convertase 
activity. 
Three regulators of the complement cascade have been previously character- 
ized, the Cl-inactivator  (28-30), C3b-inactivator,  presumably identical to C4b- 
inactivator (31, 32) and ~IH (33, 34). Cl-inactivator is a glycoprotein with a mol 
wt close to  100,000  which  stoichiometrically  inhibits  the  activity of Cls.  Al- 
though  its spectrum of activity is large,  since it also inhibits  enzymes of the 
clotting, fibrinolysis, and kallikrein systems, no interaction with C4b has been 
reported.  C3b-inactivator is a  5.5S ~2 globulin with a  mol wt of approximately 
100,000  daltons,  present in trace amounts  in serum which splits C3b (or C4b) 
2 I. Gigli, A. Ferreira, and V. Nussenzweig. Manuscript in preparation. A.  FERREIRA,  M.  TAKAHASHI,  AND  V.  NUSSENZWEIG  1015 
into two fragments.  Unlike  Ss-bp,  C3b-inactivator does not combine stoichio- 
metrically with the substrate, fllH is a heat stable 6.4s globulin of  human serum 
which potentiates  the  inactivation  of C3b by C3b-inactivator.  It has been re- 
ported that fllH binds stoichiometrically to EAC4b and EAC4b3b cells, fllH has 
a  modulating activity on the formation of cell-bound alternative  pathway C3- 
convertase  enzymes  EAC4b3bB  and  EAC~  by increasing  their  rate  of 
decay.  Although  the  mechanism  of action  of fllH  is  not  fully  understood, 
preliminary evidence suggests that in contrast to Ss-bp, its primary affinity is 
for C3b (33) rather than C4b. In short,  the characteristics  of Ss-bp are distinct 
from other known C  components.  It should be pointed out that  its properties 
bear some resemblance to an incompletely characterized 10s globulin in human 
serum which enhances the destruction of C4b by C4b-inactivator (35).  This los 
globulin  has  not  been  isolated,  and  its  similarity  with  Ss-bp  remains  to  be 
established. 
The present results also establish a functional analogy between the Ss protein 
and  C4 from two different species,  man  and  guinea  pig.  Other  investigators 
attempted to demonstrate that Ss functions as C4 in the hemolytic sequence, but 
met with only partial  success (8,  9).  The difficulties stemmed from technical 
problems encountered in the titration of mouse C in general, and in the titration 
of C4 in particular.  It remains to be established whether these difficulties are 
related to the presence of high concentrations of Ss-bp in mouse serum. 
Finally,  our  results  may  contribute  to  the  understanding  of the  relation 
between Ss and the Slp described by Passmore and Shreffler  (36,  37).  Slp is a 
serum protein,  with a  mol wt of 180,000 daltons, found in some strains of Ss-H 
mice,  but not in  Ss-L mice.  The interesting  observation has been made that, 
with one exception (38, 39) Slp is absent in females or castrated males. Several 
lines of evidence show that Ss and Slp bear common antigenic determinants.  It 
appears that  all Slp molecules have  Ss determinants,  but only some Ss mole- 
cules react  with  the  alloantiserum  to  Slp.  For this  and  other reasons  it  has 
suggested that  Slp constitutes a  subclass of Ss (39).  Genetic studies have also 
shown that the Slp locus is localized in the S region of  H-2, very closely linked to 
Ss (36). The present results suggest a  functional difference between Ss and Slp 
molecules. Indeed,  after Sephadex G-200 filtration of serum from B10.D2 male 
mice  (Ss-H,  Sip-positive),  most Ss molecules,  but no  Slp determinants,  were 
found in  the  exclusion  volume associated  with  Ss-bp  (legend  of Fig.  5 B).  In 
contrast,  as  also  shown  by Hansen  et  al.  (40)  Slp  determinants  were  found 
almost exclusively in the second peak, which contains low molecular weight Ss. 
The most likely explanation for these findings is that Slp has a lower affinity 
for Ss-bp than Ss. Perhaps only Ss is activated during clotting, or alternatively, 
both Ss and Slp may be activated, but only Ss has an affective binding site for 
Ss-bp. Because of the current interest in the interaction between products of the 
major histocompatibility complex, the intriguing  relationship between Ss, Slp, 
and  Ss-bp,  and  their  role  in  the  C  system,  is  under  investigation  in  our 
laboratory. 
Summary 
A  new  component  of the  complement  (C).system,  with  a  specific  binding 
affinity for the activated Ss-protein  (C4) has been identified in mouse serum. 1016  c4  (Ss)-BINDING  PROTEIN 
This protein, named Ss- (or C4)-binding protein (Ss-bp), was purified about 200 
times from mouse plasma. 
Ss-bp is a  heat stable (56°C,  60 rain) E-globulin with a  sedimentation coeffi- 
cient in sucrose density ultracentrifugation of 10s. Its concentration in serum of 
adult male and female mice is 160 and 60 ~g/ml, respectively. 
In EDTA-plasma, Ss and Ss-bp are not associated and can be separated by 
chromatography in Sephadex G-200.  However, in serum Ss-bp binds tightly to 
Ss. The bonds between these proteins cannot be reversed by chelation of  divalent 
cations. 
As a consequence of the formation of Ss/Ss-bp complexes, the properties of Ss- 
bp appear to be quite different in serum of mice with high (Ss-H) or low (Ss-L) 
levels of Ss-protein. In Ss-H serum, all of Ss-bp is bound to Ss. In Ss-L serum, Ss- 
bp is mostly free. Because the electrophoretic mobilities of free and complexed 
Ss-bp are quite different, Ss-bp appears to be polymorphic in serum (but not in 
EDTA-plasma). The strict dependency of the apparent electrophoretic mobility 
of Ss-bp on the levels of Ss in serum was demonstrated in a  series of congenic 
mice and among the progeny of a  cross between Ss-H and Ss-L strains of mice. 
Without exception, the slow and fast varieties of Ss-bp were associated with the 
Ss-L and Ss-H traits. 
Ss-bp of the slow variety can be transformed into the fast variety by addition 
of pure human C4,  or C4-sufficient guinea pig serum, to Ss-L serum.  In both 
instances Ss-bp formed stable complexes with C4 or a C4-derived peptide. These 
findings highlight the binding specificity of Ss-bp for the fourth component of 
the complement system, and in addition they demonstrate a  functional homol- 
ogy between the Ss-protein and C4 from two different species. 
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